Page 30 - 2021 Policy Watch
P. 30
icy Watch: Brief Analysis of the Intellectual Property Sections of Three Influential International Trade Agreements and one Bilateral Trade Agreement
5.涓撳埄鐨勫疄楠屾€т娇鐢紱 Other use without autho-
Experimental use of a pat- rization of the right holder;
ent; 6.涓撳埄鐢宠锛�
6.瀹℃煡銆佹敞鍐岀殑绋嬪簭浜� Patent filling;
椤癸紱 7.淇銆佹洿姝ｅ拰闄堣堪鎰�
Procedural aspects of ex- 瑙侊紱
amination and registra- Amendments, corrections
tion; and observations;
7.涓撳埄瀹介檺鏈燂紱 8.涓撳埄鐢宠鐨勫叕甯冿紱
Grace period for patents; Publication of patent ap-
8.涓撳埄鐢靛瓙鐢宠鍒跺害锛� plications;
Electronic patent applica- 9.涓庡凡鍏竷涓撳埄鐢宠鍜屽凡
tion system;
鎺堜簣涓撳埄鐩稿叧鐨勪俊鎭紱
9.18涓湀鍏竷锛� Information relating to
18-month publication; published patent applica-
10.鍦ㄤ簰鑱旂綉涓婂悜鍏紬 tions and granted patents;
鎻愪緵鐨勫湪鍏堟妧鏈殑淇� 10.鍥犳巿浜堟満鍏充笉鍚堢悊
鎭紱 杩熷欢鑰岃皟鏁翠笓鍒╂湡锛�
Information as prior art Patent term adjustment
made available to the pub- for unreasonable granting
lic on the Internet; authority delays;
11.蹇€熷鏌ワ紱
Expedited examination; 涓庤嵂鍝佺浉鍏崇殑鎺柦 鐩稿叧鍐呭浣嶄簬ETA鐨勭鍥�
12.寮曞叆鍥介檯涓撳埄鍒嗙被 Measures relating to phar- 鑺�
maceutical products
鍒跺害锛� 涓撳埄
Introduction of interna- 11.鍥犱笉鍚堢悊缂╃煭鑰岃皟 ETA, Section D
tional patent classification 鏁翠笓鍒╂湡锛� Patents
system; Patent term adjustment for 涓撳埄鏈夐檺鏈熺殑寤堕暱锛�
13.淇濇姢妞嶇墿鏂板搧绉嶏紱 unreasonable curtailment Effective patent term ex-
Protection of new varieties 12.鐩戠瀹℃煡渚嬪锛� tension;
of plants; Regulatory review excep-
tion;
13.淇濇姢鏈姭闇茶瘯楠屾暟
鎹垨鍏朵粬鏁版嵁锛�
Protection of undisclosed
test or other data;
14.鐢熺墿鍒跺墏锛�
Biologics;
15.鏂拌嵂鍝佺殑瀹氫箟锛�
Definition of new pharma-
ceutical product;
16.涓庨儴鍒嗚嵂鍝侀攢鍞浉
鍏崇殑鎺柦锛�
Measures relating to the
marketing of certain phar-
maceutical products;
17.淇濇姢鏈熼檺鐨勫彉鏇达紱
Alteration of period of
protection;
30
5.涓撳埄鐨勫疄楠屾€т娇鐢紱 Other use without autho-
Experimental use of a pat- rization of the right holder;
ent; 6.涓撳埄鐢宠锛�
6.瀹℃煡銆佹敞鍐岀殑绋嬪簭浜� Patent filling;
椤癸紱 7.淇銆佹洿姝ｅ拰闄堣堪鎰�
Procedural aspects of ex- 瑙侊紱
amination and registra- Amendments, corrections
tion; and observations;
7.涓撳埄瀹介檺鏈燂紱 8.涓撳埄鐢宠鐨勫叕甯冿紱
Grace period for patents; Publication of patent ap-
8.涓撳埄鐢靛瓙鐢宠鍒跺害锛� plications;
Electronic patent applica- 9.涓庡凡鍏竷涓撳埄鐢宠鍜屽凡
tion system;
鎺堜簣涓撳埄鐩稿叧鐨勪俊鎭紱
9.18涓湀鍏竷锛� Information relating to
18-month publication; published patent applica-
10.鍦ㄤ簰鑱旂綉涓婂悜鍏紬 tions and granted patents;
鎻愪緵鐨勫湪鍏堟妧鏈殑淇� 10.鍥犳巿浜堟満鍏充笉鍚堢悊
鎭紱 杩熷欢鑰岃皟鏁翠笓鍒╂湡锛�
Information as prior art Patent term adjustment
made available to the pub- for unreasonable granting
lic on the Internet; authority delays;
11.蹇€熷鏌ワ紱
Expedited examination; 涓庤嵂鍝佺浉鍏崇殑鎺柦 鐩稿叧鍐呭浣嶄簬ETA鐨勭鍥�
12.寮曞叆鍥介檯涓撳埄鍒嗙被 Measures relating to phar- 鑺�
maceutical products
鍒跺害锛� 涓撳埄
Introduction of interna- 11.鍥犱笉鍚堢悊缂╃煭鑰岃皟 ETA, Section D
tional patent classification 鏁翠笓鍒╂湡锛� Patents
system; Patent term adjustment for 涓撳埄鏈夐檺鏈熺殑寤堕暱锛�
13.淇濇姢妞嶇墿鏂板搧绉嶏紱 unreasonable curtailment Effective patent term ex-
Protection of new varieties 12.鐩戠瀹℃煡渚嬪锛� tension;
of plants; Regulatory review excep-
tion;
13.淇濇姢鏈姭闇茶瘯楠屾暟
鎹垨鍏朵粬鏁版嵁锛�
Protection of undisclosed
test or other data;
14.鐢熺墿鍒跺墏锛�
Biologics;
15.鏂拌嵂鍝佺殑瀹氫箟锛�
Definition of new pharma-
ceutical product;
16.涓庨儴鍒嗚嵂鍝侀攢鍞浉
鍏崇殑鎺柦锛�
Measures relating to the
marketing of certain phar-
maceutical products;
17.淇濇姢鏈熼檺鐨勫彉鏇达紱
Alteration of period of
protection;
30
